Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract 5506: Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations

Cancer Res (2023) 83 (7_Supplement): 5506.

https://doi.org/10.1158/1538-7445.AM2023-5506

Published: 04 April 2023

View article titled, Abstract 5506: Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations

Journal Articles

Abstract 1539: LKB1 down-modulation by miR-17 biologically and clinically mirrors LKB1-mutated NSCLC

Cristina Borzi, Monica Ganzinelli, Elisa Caiola, Marika Colombo, Giovanni Centonze, Mattia Boeri, Laura Caleca, Ugo Pastorino, Mirko Marabese, Massimo Milione, Massimo Broggini, Marina C. Garassino, Gabriella Sozzi, Massimo Moro

Cancer Res (2022) 82 (12_Supplement): 1539.

https://doi.org/10.1158/1538-7445.AM2022-1539

Published: 15 June 2022

View article titled, Abstract 1539: LKB1 down-modulation by miR-17 biologically and clinically mirrors LKB1-mutated NSCLC

Journal Articles

Abstract 2380: The effect of metabolic alterations on chemo-immunotherapy response in non-small-cell lung cancer model

Gloriana Ndembe, Mirko Marabese, Ilenia Intini, Alessandra Fabbri, Massimo Moro, Mario Occhipinti, Elisa Sottotetti, Giuseppe Lo Russo, Monica Ganzinelli, Massimo Broggini

Cancer Res (2022) 82 (12_Supplement): 2380.

https://doi.org/10.1158/1538-7445.AM2022-2380

Published: 15 June 2022

View article titled, Abstract 2380: The effect of metabolic alterations on chemo-immunotherapy response in non-small-cell lung cancer model

Journal Articles

Abstract 1669: Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts)

Cancer Res (2021) 81 (13_Supplement): 1669.

https://doi.org/10.1158/1538-7445.AM2021-1669

Published: 01 July 2021

View article titled, Abstract 1669: Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts)

Journal Articles

Abstract 4480: Circulating and tumor associated neutrophil subtypes correlate with hyperprogressive disease (HPD) upon immunecheckpoint inhibitors (ICI) in advanced non-small cell lung cancer (aNSCLC) patients (pts) and in vivo models

Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Arsela Prelaj, Giulia Galli, Nicoletta Zilembo, Alessandro De Toma, Giuseppe Viscardi, Riccardo Lobefaro, Marta Brambilla, Monica Ganzinelli, Giuliano Molino, Giovanna Talarico, Marina Chiara Garassino, Mario Colombo, Sabina Sangaletti

Cancer Res (2020) 80 (16_Supplement): 4480.

https://doi.org/10.1158/1538-7445.AM2020-4480

Published: 15 August 2020

View article titled, Abstract 4480: Circulating and tumor associated neutrophil subtypes correlate with hyperprogressive disease (HPD) upon immunecheckpoint inhibitors (ICI) in advanced non-small cell lung cancer (aNSCLC) patients (pts) and <em>in vivo</em> models

Journal Articles

Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC

Anna Tessari, Kareesma Parbhoo, Meghan Pawlikowski, Matteo Fassan, Eliana Rulli, Claudia Foray, Alessandra Fabbri, Valerio Embrione, Monica Ganzinelli, Marina Capece, Massimo Broggini, Gabriella Farina, Mirko Marabese, Marina C. Garassino, Carlo Croce, Dario Palmieri, Vincenzo Coppola

Cancer Res (2018) 78 (13_Supplement): LB-245.

https://doi.org/10.1158/1538-7445.AM2018-LB-245

Published: 01 July 2018

View article titled, Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC

Journal Articles

Abstract 760: Detection of EGFR T790M mutation by ddPCR in untreated NSCLC patients: Correlation with clinical outcome

Monica Ganzinelli, Eliana Rulli, Elena Tamborini, Adele Busico, Giuseppe Lo Russo, Giulia Corrao, Milena Vitali, Marina Chiara Garassino, Massimo Broggini, Mirko Marabese

Cancer Res (2017) 77 (13_Supplement): 760.

https://doi.org/10.1158/1538-7445.AM2017-760

Published: 01 July 2017

View article titled, Abstract 760: Detection of EGFR T790M mutation by ddPCR in untreated NSCLC patients: Correlation with clinical outcome

Journal Articles

Abstract 3739: Comparison of technologies for EGFR analysis within a subset of a randomized clinical trial

Mirko Marabese, Massimo Broggini, Martin Reijans, Cedric Gouedard, Geert Maertens, Erwin Sablon, Monica Ganzinelli, Marina C. Garassino, Samuel Murray

Cancer Res (2017) 77 (13_Supplement): 3739.

https://doi.org/10.1158/1538-7445.AM2017-3739

Published: 01 July 2017

View article titled, Abstract 3739: Comparison of technologies for <em>EGFR</em> analysis within a subset of a randomized clinical trial

Journal Articles

Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank

Federica Guffanti, Maddalena Fratelli, Monica Ganzinelli, Francesca Ricci, Roberta Affatato, Maria Rosa Cappelletti, Daniele Generali, Francesca Bizzaro, Massimo Broggini, Raffaella Giavazzi, Giovanna Damia

Cancer Res (2017) 77 (13_Supplement): 508.

https://doi.org/10.1158/1538-7445.AM2017-508

Published: 01 July 2017

View article titled, Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank

Journal Articles

Abstract 3113: SMO mutation identifies a subgroup of malignant pleural mesothelioma (MPM) patients with a worse prognosis

Monica Ganzinelli, Claudia Proto, Diego Signorelli, Laura Botta, Giulia Pasello, Marcello Tiseo, Annalisa Trama, Gemma Gatta, Adele Busico, Alessandra Fabbri, Nadia Zaffaroni, Giuseppe Pelosi, Ugo Pastorino, Filippo De Braud, Milena Vitali, Marina C. Garassino

Cancer Res (2016) 76 (14_Supplement): 3113.

https://doi.org/10.1158/1538-7445.AM2016-3113

Published: 15 July 2016

View article titled, Abstract 3113: SMO mutation identifies a subgroup of malignant pleural mesothelioma (MPM) patients with a worse prognosis

Journal Articles

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda, Rodolfo Milani, Paola Ostano, Giovanna Chiorino, Maria Rosa Bani, Giovanna Damia, Raffaella Giavazzi

Cancer Res (2014) 74 (23): 6980–6990.

https://doi.org/10.1158/0008-5472.CAN-14-0274

Published: 30 November 2014

View article titled, Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Includes: Supplementary data

NARROW

Abstract 5506: Circulating immature neutrophils early detect hyperprogressive disease upon first-line PD-1/PD-L1 inhibitors in non-small cell lung cancer patients selecting best candidates for platinum-based chemotherapy and PD-1/PD-L1 inhibitors combinations

Abstract 1539: LKB1 down-modulation by miR-17 biologically and clinically mirrors LKB1-mutated NSCLC

Abstract 2380: The effect of metabolic alterations on chemo-immunotherapy response in non-small-cell lung cancer model

Abstract 1669: Immunometabolism of circulating neutrophils in hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) alone or in combination with platinum-based chemotherapy (PCT) in non-small cell lung cancer (NSCLC) patients (pts)

Abstract 4480: Circulating and tumor associated neutrophil subtypes correlate with hyperprogressive disease (HPD) upon immunecheckpoint inhibitors (ICI) in advanced non-small cell lung cancer (aNSCLC) patients (pts) and in vivo models

Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC

Abstract 760: Detection of EGFR T790M mutation by ddPCR in untreated NSCLC patients: Correlation with clinical outcome

Abstract 3739: Comparison of technologies for EGFR analysis within a subset of a randomized clinical trial

Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank

Abstract 3113: SMO mutation identifies a subgroup of malignant pleural mesothelioma (MPM) patients with a worse prognosis

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only